Focusing on late stage science, product development and market access, Pharmabiotics Global 2017 consists of a conference, exhibition and the first-ever partnering forum dedicated to the international microbiome community.

A new industry initiative aimed at therapeutic approaches via the Human Microbiota.

Recent research has shown the importance of communication within the human microbiome (i.e. the bacteria inhabiting our body) in the maintenance of good health. Imbalances within this communication can lead to a range of gastrointestinal, vaginal, skin and autoimmune diseases.

As our understanding of this complex ecosystem of microbes grows, it is becoming increasingly apparent that the microbiota offers huge potential to the future of healthcare.

Focusing on late stage science, product development and market access, Pharmabiotics Global 2017 consists of a conference, exhibition and the first-ever partnering forum dedicated to the international microbiome community.

Conference Themes

  • Phage Therapies
  • Fecal Microbiota Transfer
  • Development Technology
  • EU & US Product Regulations
  • The Liver & Microbiome
  • Urogenital Pathologies
  • Upper-Respiratory Tract

Partnering Forum

New Partnerships. New Innovations.

Running alongside the Conference, delegates can participate in back-to-back private meetings, through our unique business networking software, bringing together the necessary players to transform the microbiota into a therapeutic reality:

  • Academics looking for commercial partners
  • Commercial enterprises looking to increase their research pipeline
  • Pharma companies searching for new therapies
  • Biotech start-ups searching for funding
  • Financiers searching for investment opportunities
  • Distributors looking to expand their product portfolio
  • Service Providers for business development

Pharmabiotics Global is organised by the Pharmabiotic Research Institute (PRI), a non-profit EU Trade Association that takes a collaborative approach to assisting its members with the developments of their Microbiotic Medicinal Products.

If you are interested in treating diseases via the Microbiota, PRI invites you to Palais Brongniart, the Historic French stock exchange in Paris, 15-17 March for 3 days of networking, exchange and turning science into therapeutic realities.

Book your place on: www.pharmabioticsevent.com

Here's To Your Health
We're reporting in on the latest in health news, medical research, insurance coverage, plus managing your health and the health of the people you love.
We respect your privacy